Tsuji Yurika, Yamamura Tomohiko, Nagano China, Horinouchi Tomoko, Sakakibara Nana, Ishiko Shinya, Aoto Yuya, Rossanti Rini, Okada Eri, Tanaka Eriko, Tsugawa Koji, Okamoto Takayuki, Sawai Toshihiro, Araki Yoshinori, Shima Yuko, Nakanishi Koichi, Nagase Hiroaki, Matsuo Masafumi, Iijima Kazumoto, Nozu Kandai
Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Pediatrics, Kyorin University School of Medicine, Mitaka, Japan.
Kidney Int Rep. 2021 Jul 16;6(10):2585-2593. doi: 10.1016/j.ekir.2021.07.010. eCollection 2021 Oct.
Frasier syndrome (FS) is a rare inherited kidney disease caused by intron 9 splicing variants of . For wild-type , 2 active splice donor sites in intron 9 cause a mixture of 2 essential transcripts (with or without lysine-threonine-serine [+/KTS or -KTS]), and imbalance of the +KTS/-KTS ratio results in the development of FS. To date, 6 causative intron 9 variants have been identified; however, detailed transcript analysis has not yet been conducted and the genotype-phenotype correlation also remains to be elucidated.
We conducted an minigene splicing assay for 6 reported causative variants and RNA sequencing to determine the +KTS/-KTS ratio using patients' samples. We also performed a systematic review of reported FS cases with a description of the renal phenotype.
The assay revealed that although all mutant alleles produced -KTS transcripts only, the wild-type allele produced both +KTS and -KTS transcripts at a 1:1 ratio. RNA sequencing showed that patients' samples with all heterozygous variants produced similar ratios of +KTS to -KTS (1:3.2-1:3.5) and wild-type kidney showed almost a 1:1 ratio (1:0.85). A systematic review of 126 cases clarified that the median age of developing ESKD was 16 years in all FS patients, and there were no statistically significant differences between the genotypes or sex chromosome karyotypes in terms of the renal survival period.
Our study suggested no differences in splicing pattern or renal survival period among reported intron 9 variants causative of FS.
弗雷泽综合征(FS)是一种由[基因名称]内含子9剪接变异引起的罕见遗传性肾脏疾病。对于野生型[基因名称],内含子9中的2个活性剪接供体位点会产生2种必需转录本的混合物(有或没有赖氨酸 - 苏氨酸 - 丝氨酸[+/KTS或 -KTS]),并且+KTS/-KTS比例失衡会导致FS的发生。迄今为止,已鉴定出6种致病性内含子9变异;然而,尚未进行详细的转录本分析,基因型与表型的相关性也仍有待阐明。
我们对6种已报道的致病性变异进行了[具体实验名称]微型基因剪接试验,并使用患者样本进行RNA测序以确定+KTS/-KTS比例。我们还对已报道的FS病例进行了系统综述,并描述了肾脏表型。
[具体实验名称]试验表明,虽然所有突变等位基因仅产生-KTS转录本,但野生型等位基因以1:1的比例产生+KTS和-KTS转录本。RNA测序显示,所有杂合变异的患者样本产生的+KTS与-KTS比例相似(1:3.2 - 1:3.5),而野生型肾脏显示的比例几乎为1:1(1:0.85)。对126例病例的系统综述表明,所有FS患者发生终末期肾病(ESKD)的中位年龄为16岁,在肾脏生存期方面,基因型或性染色体核型之间没有统计学上的显著差异。
我们的研究表明,在报道的导致FS的内含子9变异中,剪接模式或肾脏生存期没有差异。